Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia

Hussain A. Al-Omar, Hind S. Almodaimegh, Abubker Omaer, Lamya M. Alzubaidi, Bandar Al-Harbi, Ibtisam Al-Harbi, Mohamed Hassan, Omar Akhtar

Open source

DOI: 10.1080/13696998.2024.2319458
Published: 2024-03-11
Container: Journal of Medical Economics
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/13696998.2024.2319458,
  title = {Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia},
  author = {Hussain A. Al-Omar and Hind S. Almodaimegh and Abubker Omaer and Lamya M. Alzubaidi and Bandar Al-Harbi and Ibtisam Al-Harbi and Mohamed Hassan and Omar Akhtar},
  year = {2024},
  journal = {Journal of Medical Economics},
  doi = {10.1080/13696998.2024.2319458},
  url = {https://doi.org/10.1080/13696998.2024.2319458}
}

RIS

TY  - JOUR
TI  - Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia
AU  - Hussain A. Al-Omar
AU  - Hind S. Almodaimegh
AU  - Abubker Omaer
AU  - Lamya M. Alzubaidi
AU  - Bandar Al-Harbi
AU  - Ibtisam Al-Harbi
AU  - Mohamed Hassan
AU  - Omar Akhtar
PY  - 2024
JO  - Journal of Medical Economics
DO  - 10.1080/13696998.2024.2319458
UR  - https://doi.org/10.1080/13696998.2024.2319458
ER  -

APA

Al-Omar, H. A., Almodaimegh, H. S., Omaer, A., Alzubaidi, L. M., Al-Harbi, B., Al-Harbi, I., Hassan, M., & Akhtar, O. (2024). Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia. Journal of Medical Economics. https://doi.org/10.1080/13696998.2024.2319458

Source records

crossref · retrieved 2026-09-27T04:08:50.833Z